AUS
NZ
UK
CA
USA
IND
Highlights:
- Axcelis posts Q4 2024 revenue of $252.4M, a solid performance despite full-year decline.
- Gross margin improves to 46.0% in Q4, demonstrating operational efficiency.
- Q1 2025 revenue guidance of $185M reflects expected near-term cyclical challenges.
Axcelis Technologies (NASDAQ:ACLS), a leading provider of ion implantation and other wafer processing equipment, has reported its financial results for the fourth quarter (Q4) and full fiscal year 2024. The company posted Q4 revenue of $252.4 million, alongside diluted earnings per share (EPS) of $1.54. While these results reflect solid profitability for the quarter, Axcelis faced a decline in its overall financial performance for the year. Full-year 2024 revenue reached $1.02 billion, marking a 9.7% decline from $1.13 billion in 2023.
The decrease in full-year revenue was primarily driven by a decline in systems revenue, which fell to $782.6 million from $883.6 million in 2023. Despite this revenue drop, the company made significant strides in improving its profitability metrics. Gross margin improved to 44.7% for the full year, compared to 43.5% in 2023, reflecting better cost control and operational efficiency.
In Q4 alone, Axcelis saw strong improvements in its gross margin, which increased to 46.0%, up from 42.9% in Q3 2024. The company also reported an increase in operating profit for the quarter, reaching $54.5 million compared to $46.9 million in Q3. These results were a reflection of the company’s focus on improving its core operational performance, even as it navigated a challenging revenue environment.
For full-year 2024, Axcelis reported net income of $201 million and diluted EPS of $6.15, a decrease from $246.3 million and $7.43 EPS in 2023. The decline in net income was primarily a result of the reduced revenue, though the company’s improved margins helped offset some of the impact.
Looking ahead to the first quarter of 2025 (Q1 2025), Axcelis expects revenues of approximately $185 million and diluted EPS of $0.38. This reflects a significant sequential decline from Q4 2024, where the company posted revenue of $252.4 million and EPS of $1.54. Management attributes the decline to a near-term cyclical digestion period, as customers, particularly in China, absorb mature node capacity investments.
Despite the challenges in the near term, Axcelis remains focused on its strategy for future growth. The company plans to concentrate on product innovation, cost management, and enhancing customer collaboration to drive performance in the coming quarters. Management believes that the downturn is temporary and anticipates a recovery as market conditions improve and new investments are made.
